ClancysCure was created to fund research to treat and cure canine cancer at Cornell's Veterinary School and also support the crossover research between humans and canines in partnership with the Weil Cornell Medical College in New York. Both areas have exciting studies underway that can lead to advances in both human and canine treatments.

At the Veterinary School, approximately 35-40 faculty work on cancer related research interests.  Currently there are 10 faculty at Cornell with National Cancer Institute sponsored projects and numerous others with federally sponsored individual research projects directly related to cancer research.  Annual direct funds devoted to cancer research are in excess of $5 million.

Additionally, the Veterinary hospital now fields various clinical trials for dogs.  Studies include a new drug for osteosarcoma, pain medications for dogs with back surgeries, and using platelet rich plasma to treat dogs for arthritis and lameness.  Specific advances in cancer management have occurred over the last decade, in part due to clinical trials.  Improvements in diagnosis, imaging and staging have identified strategies leading to better management in supportive care and palliative management of cancer in dogs has resulted in many more options for owners considering treatment for their pets with cancer.

Cornell's College of Veterinary Medicine also sponsors research studies in Comparative Oncology.  Comparative Oncology studies naturally occurring cancers in dogs to learn more about ways to treat cancer in not just dogs, but to determine what potentially new treatments can be developed for humans too.  Cornell's research in this area is part of a growing cadre of interdisciplinary research that has made lymphoma into a prime example of the ‘one medicine’ concept — the idea that human and animal physiology, health and disease are intricately linked. The latest studies deepen the understanding of when and why dogs provide a good model for human lymphoma, as well as how human and canine lymphomas diverge in terms of their prognosis, biochemistry and gene expression. Such research holds the promise of eventually improving treatment for both species.  

Please visit for details on Cornell's current research initiatives.  We also post research updates on our ClancyCure Facebook page - please follow us!